A Wrap on 2024 as the Alzheimer’s Prevention Registry Heads Into 2025

Thank you for your continued support of our mission to end Alzheimer’s disease before losing another generation. As we kick off 2025, we are excited about the many new opportunities to participate in groundbreaking prevention research.

By Alzheimer's Prevention Bulletin

As we wrap up 2024, the team at the Alzheimer’s Prevention Registry would like to thank you for your continued support of our goal of connecting people to Alzheimer’s-focused research studies. 2024 was an exciting year and our commitment to end Alzheimer’s disease has never been stronger.

In 2024 we welcomed 8,851 new members to the Registry and have over 385,000 engaged members. Take a look at a few highlights from 2024.

• The Registry featured 58 studies
• We connected 3,738 Registry members to studies
• Top 6 most popular studies for Registry members
  • The Couples Lived Experience Study
  • Remote Cognitive Testing with BrainCheck
  • Compass for Care: Online programs for caregivers
  • Building Resilience in Mild Cognitive Impairment
  • Learning from Family and Friends Who Helped with Dementia Care
  • Arizona APOE Cohort Study
• With support from two other grants from the NIA, we were able to enroll 6,208 new members to our GeneMatch program. GeneMatch is open to adults ages 50-90 who live in the United States and who do not have a diagnosis of cognitive impairment such as Alzheimer’s disease or other dementias. If you or someone you know is in this age range and NOT already enrolled in our GeneMatch program, please visit joingenematch.org to learn more and enroll.
• Record numbers of members read our monthly Alzheimer’s Prevention Bulletin articles about research findings and the latest scientific discoveries. Here are the top 5 most read articles from 2024:
  • Prevent or Delay Dementia by Addressing 14 Risk Factors
  • Researchers Identify a Promising Blood Test for Detecting Alzheimer’s Risk
  • The APOE Gene and Risk of Alzheimer’s
  • Changing Some Lifestyle Habits Could Prevent Young-Onset Dementia
  • Groundbreaking Alzheimer's Treatment Receives FDA Approval

“2025 looks to be another busy and exciting year,” said Jessica Langbaum, PhD, Senior Director, Research Strategy at Banner Alzheimer’s Institute. “We plan on partnering with several new studies, offering you even more opportunities to participate in research. We continue to explore ways to improve your experience with the Registry and study opportunities.”

We are looking forward to new research and discoveries in 2025. And you are a key to our success! We know you signed up for the Registry to learn more about how to get involved with Alzheimer’s & dementia research to make your loved ones proud. Please encourage your friends to join too. Together we can make a difference.